Idiopathic hypereosinophilic syndrome in hemodialysis patients: Case reports

Abstract

Rationale: Herein, we report 3 hemodialysis patients with idiopathic hypereosinophilic syndrome who were successfully treated using corticosteroid therapy.

Patient concerns: Case 1 was a 63-year-old man who was undergoing hemodialysis because of bilateral nephrectomy and developed hypereosinophilia with digestive symptoms, myocardial injury, and intradialytic hypotension. Case 2 was an 83-year-old man who was undergoing hemodialysis because of nephrosclerosis and developed hypereosinophilia with pruritus, myocardial injury, and intradialytic hypotension. Case 3 was a 59-year-old man who was undergoing hemodialysis because of diabetic nephropathy and developed hypereosinophilia with pruritus, myocardial injury, and intradialytic hypotension.

Diagnoses: All 3 patients presented with hypereosinophilia (eosinophil count ≥1500 /μL for more than 1 month) and multiple-organ involvement (intradialytic hypotension, cardiac injury, digestive symptoms, and allergic dermatitis). A specific cause for the hypereosinophilia was not identified by systemic computed tomography, electrocardiography, echocardiography, bone marrow examination, or blood tests. Furthermore, Case 2 and 3 had not recently started taking any new drugs and drug-induced lymphocyte stimulation tests were negative in Case 1. Therefore, they were diagnosed with idiopathic hypereosinophilic syndrome.

Interventions: All 3 patients received corticosteroid therapy with prednisolone at a dose of 40 mg/d, 30 mg/d, and 60 mg/d in Case 1, 2, and 3, respectively.

Outcomes: Their digestive symptoms, pruritus, intradialytic hypotension, and serum troponin I concentrations were immediately improved alongside reductions in their eosinophil counts.

Lessons: There have been few case reports of idiopathic hypereosinophilic syndrome in patients undergoing hemodialysis. We believe that recording of the clinical findings and treatments of such patients is mandatory to establish the optimal management of idiopathic hypereosinophilic syndrome.

Figure 1

Clinical course of case 1. The x axis of the graph shows the number of days from admission and the y axis shows the eosinophil count (line) and the serum troponin I concentration (bars). The frequencies or durations of each clinical problem and treatment are shown below. CTA = cellulose triacetate, PS = polysulfone.

Figure 2

Clinical course of case 2. The x axis of the graph shows the number of days from admission and the y axis shows the eosinophil count (line) and the serum troponin I concentration (bars). The frequencies or durations of each clinical problem and treatment are shown below. CTA = cellulose triacetate.

Figure 3

Clinical course of case 3. The x axis of the graph shows the number of days from admission and the y axis shows the eosinophil count (line) and the serum troponin I concentration (bars). The frequencies or durations of each clinical problem and treatment are shown below. CTA = cellulose triacetate, PS = polysulfone.